Fampridin Sandoz 10 mg tablete s produljenim oslobađanjem
| Name | Fampridin Sandoz 10 mg tablete s produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-518432909 |
| Active Substance | fampridin |
| Composition | jedna tableta s produljenim oslobađanjem sadrži 10 mg fampridina |
| Pharmaceutical Form | Tableta s produljenim oslobađanjem |
| Manufacturer | Salutas Pharma GmbH, Barleben, Njemačka
Laboratorios Liconsa S.A., Azuqueca de Henares, Guadalajara, Španjolska |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 31.01.2024 |
| MA Period of Validity | 31.01.2029 |
| Classification Number | UP/I-530-09/23-01/249 |
| Registration Number | 381-12-01/286-24-06 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | N07XX07 |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
